Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Darzalex
Darzalex
J&J multiple myeloma drug succeeds in first-line combination study
Yahoo/Reuters
Tue, 11/21/17 - 09:50 am
JNJ
Multiple Myeloma
clinical trials
Darzalex
5 Key Drugs Critical to Johnson & Johnson's Future
Motley Fool
Sun, 10/22/17 - 09:50 am
JNJ
Stelara
Xarelto
Imbruvia
Zytiga
Darzalex
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
Motley Fool
Sun, 09/17/17 - 09:56 am
JNJ
Remicade
Stelara
drug pricing
Imbruvica
Xarelto
Darzalex
devices
consumer health
Genmab gains on promising early success for daratumumab PhIII in multiple myeloma, but questions linger
Endpoints
Fri, 08/25/17 - 09:49 am
Genmab
daratumumab
Darzalex
Multiple Myeloma
clinical trials
Johnson & Johnson nabs another combo approval for myeloma star Darzalex
Fierce Pharma
Mon, 06/19/17 - 03:13 pm
JNJ
Multiple Myeloma
Darzalex
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
Looking for Darzalex sales expansion, J&J, Genmab hit a wall in lymphoma
Fierce Pharma
Tue, 04/4/17 - 07:29 pm
Darzalex
JNJ
Genmab
non-Hodgkin's lymphoma
J&J pulls the plug on PhII study for NHL after Darzalex falls short
Endpoints
Thu, 03/30/17 - 06:26 pm
JNJ
clinical trials
Darzalex
4 Reasons Johnson & Johnson Surged 8% in February
Motley Fool
Thu, 03/2/17 - 03:46 pm
JNJ
Darzalex
Actelion
Donald Trump
Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand
Motley Fool
Sat, 02/25/17 - 03:21 pm
JNJ
Remicade
Darzalex
Genmab
Multiple Myeloma
Is This Johnson & Johnson's Next Billion-Dollar Blockbuster?
Motley Fool
Thu, 01/26/17 - 10:18 am
JNJ
Darzalex
Multiple Myeloma
3 Biggest Risks for Celgene Corporation
Motley Fool
Thu, 12/15/16 - 06:44 pm
Celgene
Darzalex
Multiple Myeloma
Allergan
generics
Abraxane
Revlimid
You'll Never Guess Who Owns the Most Spectacular New Cancer Drug
Motley Fool
Mon, 11/21/16 - 02:25 pm
JNJ
Darzalex
Multiple Myeloma
Here Are Johnson & Johnson's Next 10 Potential Blockbuster Drugs
Motley Fool
Wed, 11/2/16 - 10:00 am
JNJ
Darzalex
sirukumab
guselkumab
imetelstat
This $6.7 Billion Drug Just Keeps Growing
Motley Fool
Sat, 07/2/16 - 12:32 pm
JNJ
Darzalex
Celgene
Revlimid
J&J myeloma drug, in combo regimen, delays worsening of the disease
Yahoo/Reuters
Sun, 06/5/16 - 12:01 pm
JNJ
Multiple Myeloma
Darzalex
Takeda
Velcade
ASCO 2016
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
J&J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies
Fierce Biotech
Tue, 03/22/16 - 04:06 pm
JNJ
Genentech
Darzalex
atezolizumab
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016
Motley Fool
Mon, 02/8/16 - 10:23 am
Big Pharma
JNJ
Novartis
Bristol-Myers Squibb
Darzalex
Entresto
Opdivo
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
Motley Fool
Wed, 11/25/15 - 01:20 pm
JNJ
FDA
Amgen
Darzalex
daratumumab
Multiple Myeloma
Pages
« first
‹ previous
1
2
3
4
next ›
last »